These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6168688)

  • 1. Helper cells active in the generation of cytotoxicity to a syngeneic tumor.
    Hancock EJ; Kilburn DG; Levy JG
    J Immunol; 1981 Oct; 127(4):1394-7. PubMed ID: 6168688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.
    Levy JG; Maier T; Kilburn DG
    J Immunol; 1979 Mar; 122(3):766-71. PubMed ID: 109502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of an antigen-specific helper factor that enhances the in vitro generation of cytotoxic cells directed against a syngeneic tumor.
    Kilburn DG; Talbot FO; Levy JG
    J Immunol; 1981 Dec; 127(6):2465-9. PubMed ID: 6170706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a soluble factor that specifically suppresses the in vitro generation of cells cytotoxic for syngeneic tumor cells in mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1978 Apr; 120(4):1218-24. PubMed ID: 417138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2).
    Mills GB; Paetkau V
    J Immunol; 1980 Nov; 125(5):1897-903. PubMed ID: 6159395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a tumor-specific T suppressor factor from a T cell hybridoma.
    Steele JK; Stammers AT; Levy JG
    J Immunol; 1985 Apr; 134(4):2767-78. PubMed ID: 2579156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T helper cells in immune mice amplify the primary anti-tumor cytotoxic response.
    Yu AS; Bernstein ID
    J Immunol; 1982 Aug; 129(2):856-9. PubMed ID: 6177788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor.
    Biddison WE; Palmer JC; Alexander MA; Cowan EP; Manson LA
    J Immunol; 1977 Jun; 118(6):2243-53. PubMed ID: 68083
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
    Maryanski JL; Van Snick J; Cerottini JC; Boon T
    Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.
    Bour H; Horvath C; Lurquin C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Jun; 160(11):5522-9. PubMed ID: 9605156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulator T cells: involvement in the induction of cell-mediated cytotoxicity.
    Dennert G
    J Immunol; 1975 May; 114(5):1570-3. PubMed ID: 804519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accessory cell requirements for the generation of cytolytic T lymphocytes.
    Lutz CT; Fitch FW
    J Immunol; 1979 Jun; 122(6):2598-604. PubMed ID: 109533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific spontaneous cytotoxic activity in human T cell colonies.
    Price GB; Teh HS; Miller RG
    J Immunol; 1980 May; 124(5):2352-5. PubMed ID: 6767786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.